Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Seagen Inc.
Eli Lilly and Company
PMV Pharmaceuticals, Inc
NeoImmuneTech
Merck Sharp & Dohme LLC
Genmab
Tizona Therapeutics, Inc
BioInvent International AB
IDEAYA Biosciences
Eli Lilly and Company
Seagen Inc.
Novartis
Merck Sharp & Dohme LLC
Sotio Biotech Inc.
BicycleTx Limited
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Eli Lilly and Company
Mural Oncology, Inc
Merck Sharp & Dohme LLC
Toray Industries, Inc
OncoC4, Inc.
Medicenna Therapeutics, Inc.
Compugen Ltd
Sotio Biotech Inc.
Carisma Therapeutics Inc
NextCure, Inc.
Five Prime Therapeutics, Inc.
Sellas Life Sciences Group
Eli Lilly and Company
Astellas Pharma Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
ENB Therapeutics, Inc
ADC Therapeutics S.A.
Sumitomo Pharma America, Inc.
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
Ikena Oncology
Stingthera, Inc.
Atreca, Inc.
Corvus Pharmaceuticals, Inc.
Fate Therapeutics
Kineta Inc.
Tesaro, Inc.
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Merck Sharp & Dohme LLC
Incyte Corporation
Incyte Corporation